Biotechnology leads the charge with 14 stocks (GILD, MDGL, SRPT) recently rated strong buy by analysts over the past three days. Technology also shows strong momentum with upgrades to SONY and SPOT. Average target price upside suggests continued growth. However, significant downgrades in consumer discretionary, including a strong sell for NTDOY, signal caution in certain growth sectors.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.